Form D Explorer

Source evidence

Fairfield Bio, Inc. · 0002110597-26-000002

D/A filed Oct. 6, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
BRONX
street1
5454 PALISADE AVENUE
zipCode
10471
entityName
Fairfield Bio, Inc.
entityType
Corporation
stateOrCountry
NY
jurisdictionOfInc
DELAWARE
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold1945000number1945000/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amount3000000number3000000/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment0number0/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count11number11/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: 02324385dc695865a87af38d7e55f792a2af500451d669985b0f1d937ea162ae. This proves extraction identity, not the accuracy of the filer's claims.